Cardiology Department, Liverpool Centre for Cardiovascular Science, Liverpool Heart and Chest Hospital NHS Foundation Trust, Thomas Drive, Liverpool L14 3PE, UK.
Inspira Health Ltd, Oriel House, 2-8 Oriel Road, Bootle, Liverpool L20 7EP, UK.
Eur Heart J. 2022 Feb 3;43(5):405-412. doi: 10.1093/eurheartj/ehab629.
We explored whether a missed cohort of patients in the community with heart failure (HF) and left ventricular systolic dysfunction (LVSD) could be identified and receive treatment optimization through a primary care heart failure (PCHF) service.
PCHF is a partnership between Inspira Health, National Health Service Cardiologists and Medtronic. The PCHF service uses retrospective clinical audit to identify patients requiring a prospective face-to-face consultation with a consultant cardiologist for clinical review of their HF management within primary care. The service is delivered via five phases: (i) system interrogation of general practitioner (GP) systems; (ii) clinical audit of medical records; (iii) patient invitation; (iv) consultant reviews; and (v) follow-up. A total of 78 GP practices (864 194 population) have participated. In total, 19 393 patients' records were audited. HF register was 9668 (prevalence 1.1%) with 6162 patients coded with LVSD (prevalence 0.7%). HF case finder identified 9725 additional patients to be audited of whom 2916 patients required LVSD codes adding to the patient medical record (47% increase in LVSD). Prevalence of HF with LVSD increased from 0.7% to 1.05%. A total of 662 patients were invited for consultant cardiologist review at their local GP practice. The service found that within primary care, 27% of HF patients identified for a cardiologist consultation were eligible for complex device therapy, 45% required medicines optimization, and 47% of patients audited required diagnosis codes adding to their GP record.
A PCHF service can identify a missed cohort of patients with HF and LVSD, enabling the optimization of prognostic medication and an increase in device prescription.
我们探讨了是否可以通过初级保健心力衰竭(PCHF)服务来识别和治疗社区中患有心力衰竭(HF)和左心室收缩功能障碍(LVSD)的遗漏患者群体。
PCHF 是 Inspira Health、英国国家医疗服务体系心脏病专家和美敦力之间的合作项目。PCHF 服务使用回顾性临床审计来识别需要与顾问心脏病专家进行前瞻性面对面咨询的患者,以对其在初级保健中的 HF 管理进行临床审查。该服务通过五个阶段提供:(i)对全科医生(GP)系统的系统询问;(ii)病历的临床审计;(iii)患者邀请;(iv)顾问审查;以及(v)随访。共有 78 个 GP 实践(864194 人)参与。共有 19393 份患者记录接受了审计。HF 登记册为 9668 例(患病率 1.1%),其中 6162 例患者编码为 LVSD(患病率 0.7%)。HF 病例发现器确定了 9725 名需要进一步审核的患者,其中 2916 名患者需要添加 LVSD 代码到患者病历中(LVSD 增加了 47%)。HF 伴 LVSD 的患病率从 0.7%增加到 1.05%。共有 662 名患者被邀请在其当地 GP 诊所接受顾问心脏病专家的审查。该服务发现,在初级保健中,确定进行心脏病专家咨询的 HF 患者中有 27%适合进行复杂设备治疗,45%需要优化药物治疗,而接受审核的患者中有 47%需要在 GP 记录中添加诊断代码。
PCHF 服务可以识别 HF 和 LVSD 的遗漏患者群体,从而优化预后药物治疗,并增加设备处方。